Danish clinical-stage retinal diseases biotech Breye Therapeutics today announced clinical data showcasing the potential of its lead candidate, danegaptide.

Prof. Carl D. Regillo, MD, presented clinical data from the Phase 1b trial evaluating Breye Therapeutics’ lead candidate, danegaptide, in 24 patients with non-proliferative diabetic retinopathy (NPDR) ...

Getting your Trinity Audio player ready... Colorado drivers who were shocked to find themselves stuck after filling up with contaminated fuel across the Front Range last week may find relief in a new ...

Michael Kors has agreed to a settlement in a class-action lawsuit alleging it engaged in misleading advertising practices. The lawsuit, filed in 2023, alleged that the retailer "inflated" prices on ...

MINNEAPOLIS — The American Civil Liberties Union of Minnesota (ACLU) announced it filed a class action lawsuit on behalf of Minnesotans who claimed their rights have been violated by federal ...

Annexin Pharmaceuticals AB today announces favourable findings in the company's ongoing Proof of Concept Phase 2a study with the drug candidate ANXV in Diabetic Retinopathy (DR) and Retinal Vein Occlu ...

ACLU Sues Federal Government to End ICE, CBP’s Practice of Suspicionless Stops, Warrantless Arrests, and Racial Profiling of Minnesotans ACLU Sues Federal Government to End ICE, CBP’s Practice of ...

The American Civil Liberties Union is filing a class action lawsuit against the federal government on behalf of three Minnesotans — two Somali men and one Latino man — "whose constitutional rights ...

Fifteen years ago, Egyptians from all walks of life took to the street to demand “bread, freedom, social justice.” They were protesting the oppressive 30-year rule of Hosni Mubarak. Egypt had been ...

JONESBOROUGH, Tenn. (WJHL) — A Johnson City father and his son — who shot and killed a convenience store clerk in a June 2023 robbery — will each spend life in prison with the possibility of parole.